CURRENT ASSETS |
Cash and Cash Equivalents |
5.07M |
Accounts Receivable, Net |
13.41M |
Inventories, Net |
14.4M |
Prepaid Expenses and Other |
1.45M |
TOTAL CURRENT ASSETS |
34.34M |
PROPERTY, PLANT & EQUIPMENT, NET |
22.13M |
OTHER ASSETS |
Goodwill, Intangibles and Other, Net |
TOTAL ASSETS |
166.25M |
CURRENT LIABILITIES |
Accounts Payable |
3.48M |
Accrued Salaries & Payroll Taxes |
3.55M |
Notes Payable - Current Portion |
Revolving Line of Credit |
Due To Apex Laboratories, Inc. |
Other Accrued Expenses |
2.01M |
Taxes Payable |
TOTAL CURRENT LIABILITIES |
21.79M |
LONG TERM LIABILITIES |
Deferred Income Taxes Payable |
4.32M |
Notes Payable - Long Term |
STOCKHOLDERS' EQUITY |
Preferred Stock, No Par Value |
Common Stock, No Par Value; authorized 8,000,000 shares; issued and outstanding, 3,280,996 shares (6/30/11) and 3,250,736 shares (3/31/11) |
23.61M |
Employee Loans to Purchase Stock |
Retained Earnings |
67.95M |
TOTAL STOCKHOLDERS' EQUITY |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
166.25M |